Literature DB >> 18500439

Long-term remission by cyclosporine in a patient with eosinophilic fasciitis associated with primary biliary cirrhosis.

Koichiro Tahara1, Sonosuke Yukawa, Aki Shoji, Haeru Hayashi, Norioki Tsuboi.   

Abstract

A 70-year-old man was admitted to the hospital in June 1994 because of cutaneous induration of the extremities. Eosinophilic fasciitis was diagnosed on the basis of the course and distribution of the cutaneous lesions. Cyclosporine (100 mg/day) was given. After 4 weeks of treatment, cutaneous induration and limited joint mobility improved. Liver dysfunction had been diagnosed 5 years before the onset of eosinophilic fasciitis. Primary biliary cirrhosis (PBC) was diagnosed on the basis of the elevated serum biliary-enzyme levels, strongly positive antimitochondrial antibody titer, and histologic features of the liver-biopsy specimens showed stage-3 PBC. These findings suggested that eosinophilic fasciitis developed in association with PBC. PBC is often accompanied by autoimmune diseases, such as Sjögren's syndrome and Hashimoto's disease. To our knowledge, eosinophilic fasciitis associated with PBC has not been reported previously. We believe this is the first time a case of eosinophilic fasciitis occurring in a patient with PBC is documented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500439     DOI: 10.1007/s10067-008-0912-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results.

Authors:  H C Mitchison; J M Palmer; M F Bassendine; A J Watson; C O Record; O F James
Journal:  J Hepatol       Date:  1992-07       Impact factor: 25.083

Review 2.  Pharmacologic aspects of cyclosporine therapy: pharmacokinetics.

Authors:  A J Wood; M Lemaire
Journal:  Transplant Proc       Date:  1985-08       Impact factor: 1.066

3.  A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis.

Authors:  R H Wiesner; J Ludwig; K D Lindor; R A Jorgensen; W P Baldus; H A Homburger; E R Dickson
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

4.  Bone loss and reduced osteoblast function in primary biliary cirrhosis.

Authors:  S F Hodgson; E R Dickson; H W Wahner; K A Johnson; K G Mann; B L Riggs
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

5.  Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?

Authors:  L E Shulman
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

Review 6.  [Eosinophilic fasciitis with aplastic anemia and Hashimoto's thyroiditis. Review of the literature and report of a typical example].

Authors:  K U Blaser; U Steiger; A Würsch; B Speck
Journal:  Schweiz Med Wochenschr       Date:  1989-12-30

7.  Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases.

Authors:  S Lakhanpal; W W Ginsburg; C J Michet; J A Doyle; S B Moore
Journal:  Semin Arthritis Rheum       Date:  1988-05       Impact factor: 5.532

8.  Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial.

Authors:  M Lombard; B Portmann; J Neuberger; R Williams; N Tygstrup; L Ranek; H Ring-Larsen; J Rodes; M Navasa; C Trepo
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

  8 in total
  2 in total

Review 1.  Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment.

Authors:  Daniel R Mazori; Alisa N Femia; Ruth Ann Vleugels
Journal:  Curr Rheumatol Rep       Date:  2017-11-04       Impact factor: 4.592

2.  A Histologically Proven Case of Autoimmune Hepatitis with Eosinophilic Fasciitis.

Authors:  Shohei Asada; Akitoshi Douhara; Koji Murata; Koji Yanase; Masahiro Tsutsumi; Hitoshi Yoshiji
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.